Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Inclusion Criteria:

• Patient or legally authorized representative provides written authorization and/orconsent per institution and geographical requirements

• Patient has or is intended to receive or be treated with an eligible ICD or CRTdevice or Patients may be enrolled pre-implant and up to 30 days post-implantfollowing confirmation of patient eligibility.

• Patient is enrolled in the Medtronic CareLink® Network for remote monitoring.

Exclusion Criteria:

• Patient who is, or is expected to be inaccessible for follow-up

• Patient with exclusion criteria required by local law

• Patient is currently enrolled in or plans to enroll in any concurrent drug and/ordevice study that may confound results.